Found vs QuickMD
Two GLP-1 desks, one scoreboard. We put Found and QuickMD head-to-head on the published Brief Score — the same six factors, scored the same way.
Found
The verdict
Found takes this head-to-head.
Found scores 81 to 60 on our six-factor Brief Score — The widest medication bench in the ranking — compounded, brand-name and oral orforglipron — priced off a membership rather than a sticker.
That doesn't make QuickMD a bad call — it's best for cost-conscious patients wanting same-day compounded or brand glp-1 access. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Found | QuickMD | |
|---|---|---|
| Brief Score | 81/100 (B−) | 60/100 (C) |
| Semaglutide | $289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); the advertised $99 is the in-network INSURANCE rate and still sits before a ~$30 per-visit copay | From $279/mo (compounded) |
| Tirzepatide | $289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); one program price covers both molecules | Not disclosed |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
Found: Headline unchanged, but our $129 line was wrong: the published floor is $99 and it requires a 3-, 6- or 12-month plan.
QuickMD: New to the tracker on 1 August 2026. The published line reads From $279/mo (compounded) at our first reading; there is no earlier reading of ours to compare it against yet.
● Not sold on either?
CoreAge Rx tops the whole ranking at 94/100.
The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.